Senate Special Committee on Aging Seeks Briefing From Mylan (MYL) Over Epipen Pricing
Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.
(Updated - August 24, 2016 1:18 PM EDT)
The U.S. Senate Special Committee on Aging seeks to brief Mylan (Nasdaq: MYL) over Epipen pricing. PDF file is below.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Basic Energy Services (BAS) Files for Chapter 11 Bankruptcy; Appoints New Chief Restructuring Officer
- Synergy Resources (SYRG) Offers Prelim. Q3 Results; Daily Production Fell 10%
- Philip Morris (PM) Discloses Formal Probe Related to PM Thailand in 10-Q Filing